-
The Minimum Information about CLinical Artificial Intelligence Checklist for Generative Modeling Research (MI-CLAIM-GEN)
Authors:
Brenda Y. Miao,
Irene Y. Chen,
Christopher YK Williams,
Jaysón Davidson,
Augusto Garcia-Agundez,
Shenghuan Sun,
Travis Zack,
Suchi Saria,
Rima Arnaout,
Giorgio Quer,
Hossein J. Sadaei,
Ali Torkamani,
Brett Beaulieu-Jones,
Bin Yu,
Milena Gianfrancesco,
Atul J. Butte,
Beau Norgeot,
Madhumita Sushil
Abstract:
Recent advances in generative models, including large language models (LLMs), vision language models (VLMs), and diffusion models, have accelerated the field of natural language and image processing in medicine and marked a significant paradigm shift in how biomedical models can be developed and deployed. While these models are highly adaptable to new tasks, scaling and evaluating their usage pres…
▽ More
Recent advances in generative models, including large language models (LLMs), vision language models (VLMs), and diffusion models, have accelerated the field of natural language and image processing in medicine and marked a significant paradigm shift in how biomedical models can be developed and deployed. While these models are highly adaptable to new tasks, scaling and evaluating their usage presents new challenges not addressed in previous frameworks. In particular, the ability of these models to produce useful outputs with little to no specialized training data ("zero-" or "few-shot" approaches), as well as the open-ended nature of their outputs, necessitate the development of new guidelines for robust reporting of clinical generative model research. In response to gaps in standards and best practices for the development of clinical AI tools identified by US Executive Order 141103 and several emerging national networks for clinical AI evaluation, we begin to formalize some of these guidelines by building on the original MI-CLAIM checklist. The new checklist, MI-CLAIM-GEN (Table 1), aims to address differences in training, evaluation, interpretability, and reproducibility of new generative models compared to non-generative ("predictive") AI models. This MI-CLAIM-GEN checklist also seeks to clarify cohort selection reporting with unstructured clinical data and adds additional items on alignment with ethical standards for clinical AI research.
△ Less
Submitted 11 July, 2024; v1 submitted 4 March, 2024;
originally announced March 2024.
-
Identifying Reasons for Contraceptive Switching from Real-World Data Using Large Language Models
Authors:
Brenda Y. Miao,
Christopher YK Williams,
Ebenezer Chinedu-Eneh,
Travis Zack,
Emily Alsentzer,
Atul J. Butte,
Irene Y. Chen
Abstract:
Prescription contraceptives play a critical role in supporting women's reproductive health. With nearly 50 million women in the United States using contraceptives, understanding the factors that drive contraceptives selection and switching is of significant interest. However, many factors related to medication switching are often only captured in unstructured clinical notes and can be difficult to…
▽ More
Prescription contraceptives play a critical role in supporting women's reproductive health. With nearly 50 million women in the United States using contraceptives, understanding the factors that drive contraceptives selection and switching is of significant interest. However, many factors related to medication switching are often only captured in unstructured clinical notes and can be difficult to extract. Here, we evaluate the zero-shot abilities of a recently developed large language model, GPT-4 (via HIPAA-compliant Microsoft Azure API), to identify reasons for switching between classes of contraceptives from the UCSF Information Commons clinical notes dataset. We demonstrate that GPT-4 can accurately extract reasons for contraceptive switching, outperforming baseline BERT-based models with microF1 scores of 0.849 and 0.881 for contraceptive start and stop extraction, respectively. Human evaluation of GPT-4-extracted reasons for switching showed 91.4% accuracy, with minimal hallucinations. Using extracted reasons, we identified patient preference, adverse events, and insurance as key reasons for switching using unsupervised topic modeling approaches. Notably, we also showed using our approach that "weight gain/mood change" and "insurance coverage" are disproportionately found as reasons for contraceptive switching in specific demographic populations. Our code and supplemental data are available at https://github.com/BMiao10/contraceptive-switching.
△ Less
Submitted 5 February, 2024;
originally announced February 2024.
-
Large Language Models as Agents in the Clinic
Authors:
Nikita Mehandru,
Brenda Y. Miao,
Eduardo Rodriguez Almaraz,
Madhumita Sushil,
Atul J. Butte,
Ahmed Alaa
Abstract:
Recent developments in large language models (LLMs) have unlocked new opportunities for healthcare, from information synthesis to clinical decision support. These new LLMs are not just capable of modeling language, but can also act as intelligent "agents" that interact with stakeholders in open-ended conversations and even influence clinical decision-making. Rather than relying on benchmarks that…
▽ More
Recent developments in large language models (LLMs) have unlocked new opportunities for healthcare, from information synthesis to clinical decision support. These new LLMs are not just capable of modeling language, but can also act as intelligent "agents" that interact with stakeholders in open-ended conversations and even influence clinical decision-making. Rather than relying on benchmarks that measure a model's ability to process clinical data or answer standardized test questions, LLM agents should be assessed for their performance on real-world clinical tasks. These new evaluation frameworks, which we call "Artificial-intelligence Structured Clinical Examinations" ("AI-SCI"), can draw from comparable technologies where machines operate with varying degrees of self-governance, such as self-driving cars. High-fidelity simulations may also be used to evaluate interactions between users and LLMs within a clinical workflow, or to model the dynamic interactions of multiple LLMs. Developing these robust, real-world clinical evaluations will be crucial towards deploying LLM agents into healthcare.
△ Less
Submitted 19 September, 2023;
originally announced September 2023.
-
CORAL: Expert-Curated medical Oncology Reports to Advance Language Model Inference
Authors:
Madhumita Sushil,
Vanessa E. Kennedy,
Divneet Mandair,
Brenda Y. Miao,
Travis Zack,
Atul J. Butte
Abstract:
Both medical care and observational studies in oncology require a thorough understanding of a patient's disease progression and treatment history, often elaborately documented in clinical notes. Despite their vital role, no current oncology information representation and annotation schema fully encapsulates the diversity of information recorded within these notes. Although large language models (L…
▽ More
Both medical care and observational studies in oncology require a thorough understanding of a patient's disease progression and treatment history, often elaborately documented in clinical notes. Despite their vital role, no current oncology information representation and annotation schema fully encapsulates the diversity of information recorded within these notes. Although large language models (LLMs) have recently exhibited impressive performance on various medical natural language processing tasks, due to the current lack of comprehensively annotated oncology datasets, an extensive evaluation of LLMs in extracting and reasoning with the complex rhetoric in oncology notes remains understudied. We developed a detailed schema for annotating textual oncology information, encompassing patient characteristics, tumor characteristics, tests, treatments, and temporality. Using a corpus of 40 de-identified breast and pancreatic cancer progress notes at University of California, San Francisco, we applied this schema to assess the zero-shot abilities of three recent LLMs (GPT-4, GPT-3.5-turbo, and FLAN-UL2) to extract detailed oncological history from two narrative sections of clinical progress notes. Our team annotated 9028 entities, 9986 modifiers, and 5312 relationships. The GPT-4 model exhibited overall best performance, with an average BLEU score of 0.73, an average ROUGE score of 0.72, an exact-match F1-score of 0.51, and an average accuracy of 68% on complex tasks (expert manual evaluation on subset). Notably, it was proficient in tumor characteristic and medication extraction, and demonstrated superior performance in relational inference like adverse event detection. However, further improvements are needed before using it to reliably extract important facts from cancer progress notes needed for clinical research, complex population management, and documenting quality patient care.
△ Less
Submitted 11 January, 2024; v1 submitted 7 August, 2023;
originally announced August 2023.
